Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

September-October 2021; Volume 18,Issue 5

Reviews

  • You have access
    MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
    ULRICH H. WEIDLE and ADAM NOPORA
    Cancer Genomics & Proteomics September 2021, 18 (5) 591-603; DOI: https://doi.org/10.21873/cgp.20283
  • You have access
    Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
    VASILEIOS C. PEZOULAS, ORSALIA HAZAPIS, NEFELI LAGOPATI, THEMIS P. EXARCHOS, ANDREAS V. GOULES, ATHANASIOS G. TZIOUFAS, DIMITRIOS I. FOTIADIS, IOANNIS G. STRATIS, ATHANASIOS N. YANNACOPOULOS and VASSILIS G. GORGOULIS
    Cancer Genomics & Proteomics September 2021, 18 (5) 605-626; DOI: https://doi.org/10.21873/cgp.20284

Articles

  • You have access
    Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
    ARUN SETH, YUTAKA AMEMIYA, HELEN CHEUNG, EUGENE HSIEH, CALVIN LAW and LAURENT MILOT
    Cancer Genomics & Proteomics September 2021, 18 (5) 627-635; DOI: https://doi.org/10.21873/cgp.20285
  • You have access
    Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
    TAKASHI HIGUCHI, KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, MICHAEL BOUVET, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Cancer Genomics & Proteomics September 2021, 18 (5) 637-643; DOI: https://doi.org/10.21873/cgp.20286
  • You have access
    Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
    MD MOHIUDDIN and KAZUO KASAHARA
    Cancer Genomics & Proteomics September 2021, 18 (5) 645-659; DOI: https://doi.org/10.21873/cgp.20287
  • You have access
    The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
    MD MOHIUDDIN and KAZUO KASAHARA
    Cancer Genomics & Proteomics September 2021, 18 (5) 661-673; DOI: https://doi.org/10.21873/cgp.20288
  • You have access
    SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer
    JOO KYUNG NOH, SEON RANG WOO, MIYONG YUN, MIN KYEONG LEE, MOONKYOO KONG, SOONKI MIN, SU IL KIM, YOUNG CHAN LEE, YOUNG-GYU EUN and SEONG-GYU KO
    Cancer Genomics & Proteomics September 2021, 18 (5) 675-684; DOI: https://doi.org/10.21873/cgp.20289
  • You have access
    Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression
    SANGJOON CHOI, SO-WOON KIM and HYUN-SOO KIM
    Cancer Genomics & Proteomics September 2021, 18 (5) 685-698; DOI: https://doi.org/10.21873/cgp.20290
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 18 (5)
Cancer Genomics & Proteomics
Vol. 18, Issue 5
September-October 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • MicroRNAs Involved in Small-cell Lung Cancer as Possible Agents for Treatment and Identification of New Targets
  • Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile
  • Paclitaxel Impedes EGFR-mutated PC9 Cell Growth via Reactive Oxygen Species-mediated DNA Damage and EGFR/PI3K/AKT/mTOR Signaling Pathway Suppression
  • Machine Learning Approaches on High Throughput NGS Data to Unveil Mechanisms of Function in Biology and Disease
  • Multikinase-Inhibitor Screening in Drug-resistant Osteosarcoma Patient-derived Orthotopic Xenograft Mouse Models Identifies the Clinical Potential of Regorafenib
Sign up for alerts

Jump to

  • Reviews
  • Articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire